Status

Study details

Type of study

Target number of patients

200

Date of activation

15-Apr-1999

Date closed

25-Nov-2005

Approved by

CKVO Status: January 1999 Approved
CKVO 98-03

2. Patient eligibility criteria

Inclusion criteria

Age between 16 and 59 (inclusive) years. Previously untreated with chemotherapy. ALL according to the FAB criteria and immunological marker analysis (B-precursor ALL, T-ALL and AUL) WHO performance status grade 0, 1, 2 or 3. Patient informed consent.

Patients will be randomised for maintenance chemotherapy one week prior to the start of the conditioning regimen of autologous SCT, after informed consent has been obtained for either no therapy or maintenance therapy for one year.